Pitt-Hopkins Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 10 June 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
A photothermal antibacterial hydrogel based on a "nano-bridge" strategy with high toughness and self-healing capacity.
Wang Junyan et al. — Journal of colloid and interface science (15 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41638078/
- 2.
Effects of long-term exposure to ocean acidification on the Patagonian scallop Zygochlamys patagonica (P.P. king, 1832), a strategic fishery resource in the Southwest Atlantic ocean.
Lomovasky B J et al. — Marine environmental research (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41795391/
- 3.
Rapid high-throughput antibody analysis using microwave-assisted digestion.
de Toledo Thais Mingatos et al. — Journal of proteomics (20 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41570892/
- 4.
Demonstration of a
Kmak Kelly N et al. — Journal of chromatography. A (12 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41740335/
- 5.
Primary hyperoxaluria(s): from trials to real-life data and pipeline therapies.
Bacchetta Justine et al. — Kidney international (1 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41579959/
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Pitt-Hopkins Syndrome
Pitt-Hopkins syndrome is a rare neurodevelopmental condition caused by mutations in the TCF4 gene, causing intellectual disability, absent speech, characteristic facial features, and distinctive breathing abnormalities. Diagnosis has increased with molecular genetic testing. Research into TCF4 restoration strategies is emerging.
Most Recent Research
Constructing integrated multifunctional hydrogels with both high toughness and diverse functionalities is beneficial for the development of flexible antibacterial materials and wearable sensors. However, current hydrogels often fail to achieve a synergistic balance among toughness, antibacterial activity, and sensing responsiveness, limiting their practical applications. Herein, a "nano-bridge" strategy is proposed to fabricate a double-network hydrogel system (PHS-CT) composed of a covalent polyacrylamide network and a dynamic borate-crosslinked hydroxypropyl guar gum/sodium alginate network. The incorporated Cu-TA nanosheets serve not only as "structural bridges" to enhance the crosslinking density and mechanical performance (strain up to 1997.7%, toughness up to 1.53 MJ/m3), but also as "functional bridges" to enable photothermal conversion and improved antibacterial activity (bacterial killing rate of 99.0% against E. coli under NIR irradiation). In addition, benefiting from the dynamic reversibility of borate ester bonds as well as the re-forming capability of hydrogen bonds at the fracture interface, the hydrogel exhibits favorable self-healing ability (self-healing efficiency up to 91.0%), and can function as a flexible strain sensor capable of accurately detecting both large-scale and subtle deformations. This strategy provides a feasible strategy for constructing multifunctional dual-network hydrogels, and may be useful for photothermal antibacterial and flexible sensing applications.
Common Questions
What is Pitt-Hopkins Syndrome?
Pitt-Hopkins syndrome is a rare neurodevelopmental condition caused by mutations in the TCF4 gene, causing intellectual disability, absent speech, characteristic facial features, and distinctive breathing abnormalities. Diagnosis has increased with molecular genetic testing. Research into TCF4 restoration strategies is emerging.
How many clinical trials are available for Pitt-Hopkins Syndrome?
RareWays currently indexes 5 clinical trials for Pitt-Hopkins Syndrome. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Pitt-Hopkins Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Pitt-Hopkins Syndrome.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.